Page 71 - IMO-1-1

Innovative Medicines & Omics Antioxidant nanomedicines for therapies

The resilience of the intestinal microbiota influences health doi: 10.1016/j.freeradbiomed.2009.06.033
and disease. Nat Rev Microbiol. 2017;15(10):630-638.
419. Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and
doi: 10.1038/nrmicro.2017.58 therapy of psoriasis. Nature. 2007;445(7130):866-873.
408. Zhong D, Zhang D, Chen W, et al. Orally deliverable doi: 10.1038/nature05663
strategy based on microalgal biomass for intestinal disease 420. Rendon A, Schakel K. Psoriasis pathogenesis and
treatment. Sci Adv. 2021;7(48):eabi9265.
treatment. Int J Mol Sci. 2019;20(6):1475.
doi: 10.1126/sciadv.abi9265
doi: 10.3390/ijms20061475
409. Liu J, Wang Y, Heelan WJ, Chen Y, Li Z, Hu Q. Mucoadhesive
probiotic backpacks with ROS nanoscavengers enhance 421. Lin X, Huang T. Oxidative stress in psoriasis and
the bacteriotherapy for inflammatory bowel diseases. Sci potential therapeutic use of antioxidants. Free Radic Res.
Adv. 2022;8(45):eabp8798. 2016;50(6):585-595.
doi: 10.3109/10715762.2016.1162301
doi: 10.1126/sciadv.abp8798
422. Keum H, Kim TW, Kim Y, et al. Bilirubin nanomedicine
410. Zhu YX, You Y, Chen Z, et al. Inorganic nanosheet-shielded
probiotics: A self-adaptable oral delivery system for alleviates psoriatic skin inflammation by reducing
intestinal disease treatment. Nano Lett. 2023;23:4683-4692. oxidative stress and suppressing pathogenic signaling.
J Control Release. 2020;325:359-369.
doi: 10.1021/acs.nanolett.3c00118
doi: 10.1016/j.jconrel.2020.07.015
411. Cao F, Jin L, Gao Y, et al. Artificial-enzymes-armed
Bifidobacterium longum probiotics for alleviating 423. Jiang XY, Yao Q, Xia X, et al. Self-assembled nanoparticles
intestinal inflammation and microbiota dysbiosis. Nat with bilirubin/JPH203 alleviate imiquimod-induced
Nanotechnol. 2023;18:617-627. psoriasis by reducing oxidative stress and suppressing
Th17 expansion. Chem Eng J. 2022;431:133956.
doi: 10.1038/s41565-023-01346-x
doi: 10.1016/j.cej.2021.133956
412. Rawlings AV. Recent advances in skin “barrier” research.
J Pharm Pharmacol. 2010;62(6):671-677. 424. Jiang X, Huang S, Cai W, et al. Glutamine-based metabolism
normalization and oxidative stress alleviation by self-
doi: 10.1211/jpp.62.06.0002 assembled bilirubin/V9302 nanoparticles for psoriasis
413. Roberts MS, Cheruvu HS, Mangion SE, et al. Topical drug treatment. Adv Healthc Mater. 2023;12:e2203397.
delivery: History, percutaneous absorption, and product doi: 10.1002/adhm.202203397
development. Adv Drug Deliv Rev. 2021;177:113929.
425. Williams HC. Clinical practice. Atopic dermatitis. N Engl J
doi: 10.1016/j.addr.2021.113929 Med. 2005;352(22):2314-2324.
414. Tiwari N, Osorio-Blanco ER, Sonzogni A, Esporrin- doi: 10.1056/NEJMcp042803
Ubieto D, Wang H, Calderon M. Nanocarriers for skin
applications: Where do we stand? Angew Chem Int Ed Engl. 426. Spergel JM, Paller AS. Atopic dermatitis and the atopic march.
2022;61(3):e202107960. J Allergy Clin Immunol. 2003;112(6 Suppl):S118-S127.
doi: 10.1002/anie.202107960 doi: 10.1016/j.jaci.2003.09.033
415. Schneider M, Stracke F, Hansen S, Schaefer UF. 427. Dubrac S, Schmuth M, Ebner S. Atopic dermatitis: The role
Nanoparticles and their interactions with the dermal of Langerhans cells in disease pathogenesis. Immunol Cell
barrier. Dermatoendocrinol. 2009;1(4):197-206. Biol. 2010;88(4):400-409.
doi: 10.4161/derm.1.4.9501 doi: 10.1038/icb.2010.33
416. Cui M, Wiraja C, Chew SWT, Xu C. Nanodelivery systems 428. Igyarto BZ, Kaplan DH. Antigen presentation by
for topical management of skin disorders. Mol Pharm. Langerhans cells. Curr Opin Immunol. 2013;25(1):115-119.
2021;18(2):491-505. doi: 10.1016/j.coi.2012.11.007
doi: 10.1021/acs.molpharmaceut.0c00154 429. Okayama Y. Oxidative stress in allergic and inflammatory
417. Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med. skin diseases. Curr Drug Targets Inflamm Allergy.
2009;361(5):496-509. 2005;4(4):517-519.
doi: 10.1056/NEJMra0804595 doi: 10.2174/1568010054526386
418. Zhou Q, Mrowietz U, Rostami-Yazdi M. Oxidative stress 430. Corsini E, Galbiati V, Nikitovic D, Tsatsakis AM. Role of
in the pathogenesis of psoriasis. Free Radic Biol Med. oxidative stress in chemical allergens induced skin cells
2009;47(7):891-905. activation. Food Chem Toxicol. 2013;61:74-81.

Volume 1 Issue 1 (2024) 65 doi: 10.36922/imo.2527